Loading…
Lansdowne Resources' 2025 results show strategic progress: AIM readmission, graphite pivot via Sao Gabriel RTO, and $100M+ ECT claim progress.
This article covers information on Lansdowne Resources PLC.
LON:LRESLansdowne Resources’ audited 2025 results are not really about profits, production or cash generation. They are about survival, restructuring and setting up the next chapter. For retail investors, that matters because this was a business with suspended AIM trading, very little cash and an unresolved dispute over Barryroe – and it has now managed to get back onto the market with a new asset base and funding in place.
The headline message is fairly simple. 2025 was weak financially, but strategically it was a year of progress that led to two big outcomes after the year end: readmission to AIM on 27 May 2026 and tangible movement on its Energy Charter Treaty, or ECT, legal claim against Ireland.
| Metric | 2025 | 2024 |
|---|---|---|
| Cash balance at year end | £0.006 million | £0.01 million |
| Operating expenses | £0.9 million | £0.3 million |
| Loss after tax | £0.9 million | £0.3 million |
| Diluted loss per share | 0.06 pence | 0.02 pence |
| LC Capital loan at year end | £1.149 million | £1.085 million |
| Total net liability attributable to ordinary shareholders | £2.07 million | £1.27 million |
Those figures are not pretty. The cash position at 31 December 2025 was just £0.006 million, which is only £6,000. Losses widened, operating costs jumped, and net liabilities deepened.
On that basis alone, this does not read like a healthy standalone small-cap. It reads like a company that needed a deal, needed funding and needed time.
The big strategic move was the reverse takeover, or RTO, of Sao Gabriel Mineracao Ltda., a Brazilian mining company with graphite assets. A reverse takeover is when a listed shell or struggling quoted company buys a business large enough to effectively become the new core operation.
That matters because Lansdowne was previously known for oil and gas exposure through Barryroe. Now it is pivoting into graphite, which the company describes as part of the growing critical minerals sector. That is a major change in investment case.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
0 viewsLikes
No ratings yet
The RTO was announced in April 2026 and approved by shareholders on 26 May 2026. Readmission to AIM followed on 27 May 2026, ending the suspension that had remained in place through 2025.
In plain English, Lansdowne is no longer just a legal claim wrapped in a suspended shell. It is back on market with a new operating direction, however early-stage that new direction still is.
The fresh money is important. The company said net proceeds will be used to advance the Macaubas Graphite Project through an active exploration programme and for general working capital. The next phase of field work on the graphite tenements is expected to start in the third quarter of 2026.
That gives investors something concrete to watch. But it is still early stage. The RNS says the graphite assets have shown “promising early stage results” and that early results indicated high grades. There is no resource estimate, development timeline or economic study disclosed here.
The other big piece of the story is the Barryroe arbitration claim. Lansdowne says the gross compensation claim is expected to be in excess of $100 million, plus accrued interest and any related penalties.
This is being pursued under the Energy Charter Treaty after Ireland refused the Lease Undertaking for Barryroe in May 2023. Lansdowne secured third-party litigation funding in December 2025, which is a big step because the funding is described as non-recourse. That means if the case fails, the funder generally bears the loss rather than the company having to repay legal costs in the usual way.
That is a clear positive. For a company with only £0.006 million of cash at year end, self-funding a major international arbitration would have been a serious problem. Litigation funding keeps the claim alive without draining what little cash the group had.
The RNS gives a useful steer here. If there were a successful award of approximately $100 million, Lansdowne’s share of proceeds under the funding agreements with Diamond McCarthy and Mantle Law is expected to be between 60% and 70%.
There is also a shareholder distribution angle. Following the May 2026 transaction, preference shares were used to ringfence the majority – approximately 80% – of any potential net award for existing shareholders and convertible loan note holders. The RNS also says shareholders on admission are entitled to 20% of the net proceeds of any successful ECT claim.
The case has now been registered at ICSID, the International Centre for the Settlement of Investment Disputes, and the next step is appointing a tribunal. That means the claim has moved beyond talk and into formal process, but investors should remember these cases can take a long time and outcomes are uncertain.
Lansdowne relied heavily on funding support while it was suspended. In 2025, it entered into an additional £145,000 of convertible loan notes, and a further £220,000 were issued in 2026, taking the total to £440,000 issued between 2024 and 2026. All of those converted into new ordinary shares on readmission to AIM.
That helped bridge the business through a very tight period, but it also means dilution. The notes converted at the lower of 0.1 pence or a 20% discount to the share issue price at the time of the reverse takeover. Existing investors were effectively paying the price of keeping the listed vehicle alive.
The LC Capital Master Fund loan was also extended again. It stood at £1.149 million at 31 December 2025 and has now been extended for a further 18 months from readmission to 27 November 2027.
That extension buys breathing space, which is helpful. But debt extensions are not the same thing as debt disappearing.
My view is that the historic 2025 numbers are weak, but the overall announcement is more positive than negative. If you only looked at the profit and loss account, you would see a loss-making company with almost no cash. If you look at the full RNS, you see a company that has secured litigation funding, completed a strategic pivot, raised new capital and got its AIM listing back.
That does not make it low risk. Far from it. Lansdowne now depends on two uncertain value drivers: early-stage graphite exploration in Brazil and a high-stakes international arbitration claim. Neither is guaranteed, and neither will turn into cash overnight.
Still, this result matters because it marks the point where Lansdowne stopped just treading water. The company now has a route back into operations and a formal legal process underway on Barryroe. For a business that spent 2025 suspended and financially stretched, that is meaningful progress.
The bottom line is this: Lansdowne’s 2025 accounts show where the strain was, but the post-period events show why the company is still in the game. For shareholders, the real debate now is not about last year’s loss. It is whether the new graphite strategy and the Barryroe legal claim can create enough value to justify the rescue effort.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.